Birgitte Volck

CIK 1762371 · President of R&D · last filed 2026-05-18

Birgitte Volck is a President of R&D who has filed 21 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for SLNO, was dated May 18, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

21

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SLNO Director 0 $53.01 $0 $0 18 2026-05-18
Tectonic Therapeutic, Inc. (AVRO) Delisted President of R&D $16.80 $0 2 2020-03-06
SOLENO THERAPEUTICS INC (SLNOW) Delisted Director $0 1 2019-06-12

Recent Filings

21 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-18 SLNO Disp (D) −17,536 $0 EDGAR
2025-06-09 SLNO Grant (A) +3,991 $0 EDGAR
2024-06-10 SLNO Grant (A) +6,500 $0 EDGAR
2023-06-05 SLNO Grant (A) $0 EDGAR
2022-10-14 SLNO $0 EDGAR
2022-10-14 SLNO Grant (A) $0 EDGAR
2022-02-02 SLNO Grant (A) +35,915 $12.7K EDGAR
2021-11-02 SLNO Grant (A) +17,141 $0 EDGAR
2021-08-03 SLNO Grant (A) +14,010 $12.7K EDGAR
2021-06-04 SLNO Grant (A) $0 EDGAR
Showing 110 of 21
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.